Role of anemia in acute and chronic heart failure and the role of erythropoietin in its correction

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The World Health Organization considers anemia in adults to be present when the hemoglobin (Hb) of men is <13 g/dL and of women is <12 g/dL (1). The average lower limit of a normal Hb for men and women together, therefore, is about 12.5 g/dL, and anything less than this would be considered to be anemia. In a study of 32,229 consecutive patients admitted to 263 United States hospitals with a primary diagnosis of congestive heart failure (CHF) (the Acute Decompensated Heart Failure National Registry [ADHERE] study), the mean Hb was 12.4 g/dL and the mean serum creatinine was 1.8 mg/dL (2) (roughly equivalent to a calculated creatinine clearance of about 40 mL/min/1.73 m2). Clearly, then, about half the patients admitted to hospital with a primary diagnosis of CHF in the U.S. have anemia and, since a creatinine clearance of <60 mL/min/1.73 m2 is considered to be chronic kidney insufficiency (CKI), the great majority also have CKI. © 2008 Springer-Verlag London.

Cite

CITATION STYLE

APA

Silverberg, D. S., Wexler, D., Iaina, A., & Schwartz, D. (2008). Role of anemia in acute and chronic heart failure and the role of erythropoietin in its correction. In Acute Heart Failure (pp. 519–527). Springer London. https://doi.org/10.1007/978-1-84628-782-4_48

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free